Co-Authors
This is a "connection" page, showing publications co-authored by Marcus Schultz and Alexander Vlaar.
Connection Strength
0.840
-
Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial. Lancet Rheumatol. 2020 Dec; 2(12):e764-e773.
Score: 0.226
-
Subphenotyping Acute Respiratory Distress Syndrome in Patients with COVID-19: Consequences for Ventilator Management. Ann Am Thorac Soc. 2020 09; 17(9):1161-1163.
Score: 0.225
-
Supernatant of aged erythrocytes causes lung inflammation and coagulopathy in a "two-hit" in vivo syngeneic transfusion model. Anesthesiology. 2010 Jul; 113(1):92-103.
Score: 0.111
-
Assessment of Lung Reaeration at 2 Levels of Positive End-expiratory Pressure in Patients With Early and Late COVID-19-related Acute Respiratory Distress Syndrome. J Thorac Imaging. 2021 Sep 01; 36(5):286-293.
Score: 0.060
-
Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study. Lancet Respir Med. 2021 02; 9(2):139-148.
Score: 0.057
-
PRactice of VENTilation in Patients with Novel Coronavirus Disease (PRoVENT-COVID): rationale and protocol for a national multicenter observational study in The Netherlands. Ann Transl Med. 2020 Oct; 8(19):1251.
Score: 0.057
-
Update for Anaesthetists on Clinical Features of COVID-19 Patients and Relevant Management. J Clin Med. 2020 May 15; 9(5).
Score: 0.055
-
RELAx - REstricted versus Liberal positive end-expiratory pressure in patients without ARDS: protocol for a randomized controlled trial. Trials. 2018 May 09; 19(1):272.
Score: 0.048